Study Highlights Major Gaps in Opioid Use Disorder Treatment for Youth

A new study led by Mass General Brigham researchers, published on October 2, 2026, in JAMA Network Open, reveals substantial gaps in evidence-based care for Medicaid-enrolled adolescents and young adults (13-25 years old) with opioid use disorder (OUD). The study, which analyzed eight years of national data, found that only half of these patients began treatment, one-third engaged in care, and only one in thirty-two continued medication for 180 days or more.

Context

Opioid use disorder has become a significant concern in the United States, particularly among youth. Medicaid serves as a primary source of healthcare for many adolescents and young adults, yet the study reveals that a large percentage of those eligible for treatment are not receiving adequate care. Understanding the barriers to treatment is crucial for developing effective interventions.

Why it matters

The study underscores a critical public health issue, highlighting the insufficient treatment options available for young people facing opioid use disorder. With rising rates of opioid addiction among adolescents, addressing these gaps is essential to improve health outcomes. Ensuring access to effective treatment can help mitigate long-term consequences associated with opioid misuse.

Implications

The findings may prompt healthcare providers and policymakers to reevaluate current treatment protocols for young people with opioid use disorder. If gaps in care are addressed, it could lead to better health outcomes for this vulnerable population. Families and communities may also benefit from increased awareness and resources dedicated to treating opioid addiction in youth.

What to watch

In the near term, stakeholders may push for policy changes aimed at improving access to treatment for youth with opioid use disorder. Increased funding for mental health services and substance use treatment programs could be on the agenda. Additionally, further research may emerge to explore the reasons behind low engagement and retention rates in treatment.